Immunomedics, Inc. (NASDAQ:IMMU)
| CAPS Rating |
|
|---|
IMMU
VS S&P 500 (SPY)
IMMU News and Commentary
- Has Immunomedics Become the Perfect Stock? – The Motley Fool
- UCB-Astellas Collaborate - Analyst Blog – NASDAQ
- CNS Cure Priority for UCB & Partner - Analyst Blog – NASDAQ
- UCB-Immunomedics Restructure Deal - Analyst Blog – NASDAQ
- Biotech Post-Holiday Regifting – The Motley Fool
- 7 Reasons to Worry About Next Week – The Motley Fool
- Investing 101: Rallying Stocks Under $5 Undervalued to Analyst Estimates – The Motley Fool
- The 10 Most-Watched Diagnostic Substances Stocks – The Motley Fool
- A Simplified ASCO 2011 List for Biotech Investor Research – SeekingAlpha
How do you think IMMU will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
200
Outperform
14
Underperform
All-Star Players
38
Outperform
2
Underperform
Wall Street
5
Outperform
0
Underperform
RSS Headlines
Fool UK
